Clinical Value of CD24 Expression in Retinoblastoma

Figure 2

Western blot analysis for CD24 protein expression in retinoblastoma tissues, with non-neoplastic retina as control. The picture shows that CD24 was negative in non-neoplastic retina (lane 0), strongly expressed in 5 (83.3%, lanes 1~5) and faintly expressed in 1 (16.7%, lanes 6) high-risk tumors, whereas it was strongly expressed in 2 (50.0%, lanes 7~8) and faintly expressed in 2 (50.0%, lanes 9~10) low-risk tumors.